146 related articles for article (PubMed ID: 21532187)
1. Formulation variation and in vitro-in vivo correlation for a rapidly swellable three-layered tablet of tamsulosin HCl.
Park JS; Shim JY; Park JS; Lee MJ; Kang JM; Lee SH; Kwon MC; Choi YW; Jeong SH
Chem Pharm Bull (Tokyo); 2011; 59(5):529-35. PubMed ID: 21532187
[TBL] [Abstract][Full Text] [Related]
2. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
Park JS; Shim JY; Park JS; Choi YW; Jeong SH
Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
[TBL] [Abstract][Full Text] [Related]
3. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
4. Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating.
Maeda A; Shinoda T; Ito N; Baba K; Oku N; Mizumoto T
Int J Pharm; 2011 Apr; 408(1-2):84-90. PubMed ID: 21291970
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoscintigraphy confirms consistent tamsulosin release from a novel triple-layered tablet.
Hodges LA; Sime KA; Creech LA; Connolly SM; Barclay ST; Kwon MC; Jeon BJ; Shim SM; Wang HS; Stevens HN; Park JS
Int J Pharm; 2013 Sep; 454(1):41-6. PubMed ID: 23834829
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vivo evaluation of spray dried matrix type controlled-release microparticles of tamsulosin hydrochloride for orally disintegrating tablet.
Park CW; Kim JY; Rhee YS; Oh TO; Ha JM; Park ES
Drug Dev Ind Pharm; 2012 Oct; 38(10):1179-87. PubMed ID: 22200122
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive evaluation of layer separation tendency of novel three-layered tablets with geometric and mechanical properties.
Choi du H; Lim DG; Son HM; Jeong SH
Int J Pharm; 2014 Apr; 465(1-2):347-59. PubMed ID: 24530386
[TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo characteristics of a modified-release double-pulse formulation for a water soluble drug.
Avramoff A; Domb AJ
Int J Clin Pharmacol Ther; 2010 Apr; 48(4):250-8. PubMed ID: 20353746
[TBL] [Abstract][Full Text] [Related]
9. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
10. Development of sustained-release microparticles containing tamsulosin HCl for orally disintegrating tablet using melt-adsorption method.
Cho CH; Min JH; Hwang KM; Park ES
Drug Deliv Transl Res; 2018 Jun; 8(3):552-564. PubMed ID: 29359246
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
Jantratid E; Prakongpan S; Amidon GL; Dressman JB
Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
[TBL] [Abstract][Full Text] [Related]
12. Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans.
Kim KH; Lim SH; Shim CR; Park J; Song WH; Kwon MC; Lee JH; Park JS; Choi HG
Drug Des Devel Ther; 2020; 14():445-456. PubMed ID: 32099329
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial.
van Kerrebroeck P; Chapple C; Drogendijk T; Klaver M; Sokol R; Speakman M; Traudtner K; Drake MJ;
Eur Urol; 2013 Dec; 64(6):1003-12. PubMed ID: 23932438
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
16. Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
Stevens HN; Speakman M
Curr Med Res Opin; 2006 Dec; 22(12):2323-8. PubMed ID: 17257446
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.
Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL
Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037
[TBL] [Abstract][Full Text] [Related]
18. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
Raut Desai S; Rohera BD
Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
[TBL] [Abstract][Full Text] [Related]
19. Extended release dosage form of glipizide: development and validation of a level A in vitro-in vivo correlation.
Ghosh A; Bhaumik UK; Bose A; Mandal U; Gowda V; Chatterjee B; Chakrabarty US; Pal TK
Biol Pharm Bull; 2008 Oct; 31(10):1946-51. PubMed ID: 18827360
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]